Paul D. Uhlendorf

Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation.

Thomas Bocan, Sandra Bak Mueller, Paul D. Uhlendorf et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1991 · 157 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation

Thomas Bocan, Sandra Bak Mueller, Paul D. Uhlendorf et al. · Atherosclerosis · 1993 · 114 citations

Life Sciences, Cardiology, Nutritional Sciences +12

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

Thomas Bocan, Erika Ferguson, W. McNally et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1992 · 86 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation

Thomas Bocan, Sandra Bak Mueller, Edie Quenby Brown et al. · Atherosclerosis · 1994 · 80 citations

Life Sciences, Biochemistry, Pharmacology +13

Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand White rabbits

Thomas Bocan, Sandra Bak Mueller, Edie Quenby Brown et al. · Experimental and Molecular Pathology · 1992 · 45 citations

Veterinary Medicine, Biochemistry, Rabbit Medicine +10